%0 Journal Article
%K Humans
%K *Diabetes Mellitus, Type 2/drug therapy/epidemiology/complications
%K *Dipeptidyl-Peptidase IV Inhibitors/adverse effects
%K Cohort Studies
%K Sulfonylurea Compounds/adverse effects
%K *Skin Neoplasms/chemically induced/epidemiology/complications
%K *Melanoma/epidemiology/complications
%K Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
%K Dipeptidyl Peptidase 4
%K Drug Effects
%K Medical Oncology
%K pharmacoepidemiology
%B BMJ Open Diabetes Res Care
%D 2023
%G eng
%M 37949470
%R 10.1136/bmjdrc-2023-003550
%T Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
%V 11
%2 PMC10649616
%7 2023/11/11
%@ 2052-4897